Source: Health Canada shortage reports · Updated Jul 23, 2026
Some Bromazepam products are in shortage in Canada (1 of 9 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Sep 18, 2026.
A benzodiazepine used to treat anxiety.
Products affected
1 / 9
In shortage since
Jul 14, 2026
Est. full return
Sep 18, 2026
Reports on file
19
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
APO-BROMAZEPAM
3MG · TABLET · APOTEX INC
DIN 02177161 · since Jul 14, 2026, est. end Sep 18, 2026 · Disruption of the manufacture of the drug.
Resolved
TEVA-BROMAZEPAM
6MG · TABLET · TEVA CANADA LIMITED
DIN 02230585 · ended Aug 19, 2025 · Disruption of the manufacture of the drug.
Resolved
APO-BROMAZEPAM
3MG · TABLET · APOTEX INC
DIN 02177161 · ended Oct 24, 2024 · Disruption of the manufacture of the drug.
Resolved
TEVA-BROMAZEPAM
3MG · TABLET · TEVA CANADA LIMITED
DIN 02230584 · ended Sep 8, 2021 · Disruption of the manufacture of the drug.
Resolved
TEVA-BROMAZEPAM
6MG · TABLET · TEVA CANADA LIMITED
DIN 02230585 · ended Oct 14, 2020 · Disruption of the manufacture of the drug.
Resolved
TEVA-BROMAZEPAM
3MG · TABLET · TEVA CANADA LIMITED
DIN 02230584 · ended May 7, 2020 · Disruption of the manufacture of the drug.
Resolved
TEVA-BROMAZEPAM
6MG · TABLET · TEVA CANADA LIMITED
DIN 02230585 · ended Mar 11, 2020 · Disruption of the manufacture of the drug.
Resolved
TEVA-BROMAZEPAM
3MG · TABLET · TEVA CANADA LIMITED
DIN 02230584 · ended Feb 6, 2020 · Disruption of the manufacture of the drug.
Discontinued
BROMAZEPAM-6 - TAB 6MG
6MG · TABLET · PRO DOC LIMITEE
DIN 02220539
Discontinued
APO-BROMAZEPAM - TAB 3MG
3MG · TABLET · APOTEX INC
DIN 02177161
Discontinued
BROMAZEPAM-3 - TAB 3MG
3MG · TABLET · PRO DOC LIMITEE
DIN 02220520
Resolved
BROMAZEPAM-3 - TAB 3MG
3MG · TABLET · PRO DOC LIMITEE
DIN 02220520 · ended Apr 10, 2019 · Discontinued
Discontinué
Showing 12 of 19 reports. All reports are on file with Health Canada.
What's happening
Bromazepam is currently affected by an active shortage report filed with Health Canada by APOTEX INC.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Bromazepam is classified under “ANXIOLYTICS” (ATC N05BA).
Recent changes
Jul 23, 2026
Estimated end date pushed back : Aug 28, 2026 → Sep 18, 2026
Jul 16, 2026
New report filed
Common questions
What is Bromazepam used for?
A benzodiazepine used to treat anxiety.
When will Bromazepam be back in stock in Canada?
The latest manufacturer estimate is Sep 18, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Bromazepam in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Possible alternatives in the same class (anxiolytics)
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.